July 21, 2022 (Investorideas.com Newswire) Vancouver-based pharmaceutical development firm Algernon Pharmaceuticals Inc. recently reported topline data from a Phase 2a trial of ifenprodil in IPF patients with chronic cough

By sahil

Leave a Reply

Your email address will not be published.